Trending Topics

 

Check out the latest cancer-related news and also see who is readily available to offer reliable information, expert commentary, and reaction to today's headlines.
Contact a media coordinator

The 2016 ASTRO Annual Meeting will take place in Boston from September 25 to 28. Featuring new insights and discoveries from leading institutions around the world, this scientific forum will include presentations and data that could affect the way cancer care is planned and delivered. Memorial Sloan Kettering radiation oncologists are available to comment on meeting news and presentations. Follow the meeting live on Twitter using the hashtag #ASTRO16. For more information or to speak with an expert, contact mediastaff@mskcc.org.
Friday, September 23, 2016
 
A new drug is being shown to extend the lives of patients with advanced soft tissue sarcoma by almost a year. The results of a multicenter phase II trial evaluating the efficacy and safety of olaratumab in combination with doxorubicin chemotherapy was published in The Lancet on June 9. William Tap, MD, Chief of the Sarcoma Medical Oncology Service at Memorial Sloan Kettering Cancer Center (MSK), served as corresponding author on this study, which met its primary endpoint of progression-free survival and showed a statistically significant improvement in overall survival. To arrange an interview with Dr. Tap, please email mcnamarn@mskcc.org.
Friday, June 10, 2016
 
MSK researchers are presenting nearly 120 studies at the 2016 Annual Meeting of the American Society of Clinical Oncology.
Friday, June 3, 2016
 
See all trending topics
 

Press Releases

 
Nearly 20 years have passed since Memorial Sloan Kettering Cancer Center (MSK) first opened its doors in the Garden State. Since then, an explosion of knowledge and data has resulted in far better outcomes for thousands of people with cancer, including many who’ve sought care at MSK’s facility in New Jersey.
Monday, November 28, 2016
 
Memorial Sloan Kettering Cancer Center (MSK), The Rockefeller University and Weill Cornell Medicine announced today that they have established a new drug discovery company called Bridge Medicines. Launched in partnership with Takeda Pharmaceutical Company Ltd. and healthcare investment firms Bay City Capital and Deerfield Management, Bridge Medicines is a groundbreaking initiative that completes a seamless, fully funded and professionally staffed path from concept to drug candidate to efficiently and rapidly develop innovative therapeutics for treating human diseases.
Monday, October 31, 2016
 
When Memorial Sloan Kettering Cancer Center (MSK) opened its doors along Commack Road in 2002, eastern Long Islanders no longer needed to navigate congested roadways and train lines bound for Manhattan to receive personalized cancer care. Today, more than 14 years later, MSK is reinforcing its commitment to the local community in the form of a 38,000-plus-square-foot addition complete with enhancements to both clinical programs and physical spaces.
Monday, October 17, 2016
 
See all press releases
 

On Our Blog

 
IN THE LAB
Scientists are looking to exploit defects in DNA repair as an Achilles’ heel in cancer.
Friday, December 9, 2016
 
IN THE CLINIC
Women who have reconstructive surgery after mastectomy and radiation for breast cancer are usually more satisfied with the results when their own tissue is used instead of implants.
Thursday, December 8, 2016
 
FEATURE
Learn how to go about making an appointment at Memorial Sloan Kettering.
Monday, December 5, 2016
 
See all blog posts
 

Media Coverage

 
Surgeon Prasad Adusumilli was interviewed about how older patients can survive and even thrive after lung surgery in NPR Shots Blog.
Monday, November 21, 2016
 
Medical oncologist Sham Mailankody’s research published in JAMA Oncology is featured in STAT News.
Monday, November 21, 2016
 
WebMD and Robin Roberts share the stories of patients across America who have survived cancer using breakthroughs in treatment. Ms. Roberts spoke of her own cancer battles in an episode focused on integrative medicine, which features footage captured during her courageous and hard-fought journey, as well as a powerful interview with hematologic oncologist Sergio Giralt. 
Wednesday, November 16, 2016
 
See all media coverage
 

If you wish to contact MSK about a marketing or advertising related opportunity, or are looking for additional information about our ad campaign, please email us at marketing@mskcc.org.

For Journalists

Jeanne D'Agostino
Director, Media and Public Relations
 
Emily O'Donnell
Senior Communications Associate, Department of Surgery
 
Courtney Nowak
Senior Media Relations Associate
 
Caitlin Hool
Senior Media Associate
 
Nicole H. McNamara
Senior Media Relations Associate
 
Rebecca Williams
Media Associate
 
For press inquiries, our Media Staff are available by calling 646-227-3573 or by dialing the numbers above. Our office hours are Monday - Friday, 9:00 AM to 5:00 PM.
 
After hours, please contact the hospital's page operator at 212-639-7900 and ask for the Public Affairs representative on-call.

Live and Remote Broadcast Capabilities

Our experts can offer live broadcast interviews using the on-site studio system. To book an expert interview using our on-site broadcast studio contact our Media Staff.

News@MSKCC

Get the latest information from our media staff on advances in research at MSK.

Newsletter Sign Up Unsubscribe